A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.
Public ClinicalTrials.gov record NCT04057118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study to Evaluate the Efficacy and Safety of Oral SKI-O-703 in Patients With Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies
Study identification
- NCT ID
- NCT04057118
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Oscotec Inc.
- Industry
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Interventions
- SKI-O-703 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 19, 2019
- Primary completion
- Oct 12, 2020
- Completion
- Oct 12, 2020
- Last update posted
- Jul 30, 2024
2019 – 2020
United States locations
- U.S. sites
- 12
- U.S. states
- 6
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Oscotec Investigational Site (Site 3110) | Beverly Hills | California | 90211 | — |
| Oscotec Investigational Site (Site 3105) | Upland | California | 91786 | — |
| Oscotec Investigational (Site 3104) | Miami Lakes | Florida | 33014 | — |
| Oscotec Investigational Site (Site 3112) | Tampa | Florida | 33614 | — |
| Oscotec Investigational Site (Site 3108) | Lexington | Kentucky | 40504 | — |
| Oscotec Investigational Site (Site 3102) | Oklahoma City | Oklahoma | 73103 | — |
| Oscotec Investigational Site (Site 3107) | Duncansville | Pennsylvania | 16635 | — |
| Oscotec Investigational Site (3106) | Carrollton | Texas | 75010 | — |
| Oscotec Investigational Site (Site 3111) | Houston | Texas | 77034 | — |
| Oscotec Investigational Site (Site 3109) | Mesquite | Texas | 75150 | — |
| Oscotec Investigational Site (Site 3103) | San Antonio | Texas | 78229 | — |
| Oscotec Investigational Site (Site 3101) | Tomball | Texas | 77375 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04057118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04057118 live on ClinicalTrials.gov.